Budget Impact Analysis of Introducing Biosimilar Infliximab for the Treatment of Auto Immune Disorders In Five European Countries
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1655
https://www.valueinhealthjournal.com/article/S1098-3015(14)03585-2/fulltext
Title :
Budget Impact Analysis of Introducing Biosimilar Infliximab for the Treatment of Auto Immune Disorders In Five European Countries
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03585-2&doi=10.1016/j.jval.2014.08.1655
First page :
A525
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1128